Australia markets closed

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
43.16-0.68 (-1.55%)
As of 11:47AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
118,370
234,195
118,719
147,703
Other short-term investments
217,630
128,599
622,203
220,310
Total cash
336,000
362,794
740,922
368,013
Net receivables
233,254
186,970
90,975
97,730
Inventory
127,601
100,123
53,908
60,747
Other current assets
48,613
45,024
40,482
28,274
Total current assets
746,424
739,013
926,287
554,764
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
94,605
90,326
21,894
22,175
Accumulated depreciation
-19,661
-14,756
-13,100
-11,582
Net property, plant and equipment
74,944
75,570
8,794
10,593
Goodwill
416,821
409,049
0
-
Intangible assets
472,879
546,652
-
-
Other long-term assets
17,816
26,801
13,914
14,567
Total non-current assets
986,846
1,102,498
178,142
25,160
Total assets
1,733,270
1,841,511
1,104,429
579,924
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
13,334
89,419
397,228
Accounts payable
11,816
17,693
1,541
1,928
Accrued liabilities
100,678
99,762
24,441
20,483
Deferred revenues
-
3,246
1,746
1,746
Total current liabilities
112,494
130,789
117,147
421,385
Non-current liabilities
Long-term debt
1,499,248
1,492,766
787,255
-
Deferred revenues
-
2,253
2,530
4,026
Other long-term liabilities
37,720
48,158
544
3,466
Total non-current liabilities
1,536,968
1,540,924
790,329
7,492
Total liabilities
1,649,462
1,671,713
907,476
428,877
Stockholders' equity
Common stock
127
135
138
135
Retained earnings
90,550
143,217
-58,912
-474,593
Accumulated other comprehensive income
-9,278
-922
-620
22
Total stockholders' equity
83,808
169,798
196,953
151,047
Total liabilities and stockholders' equity
1,733,270
1,841,511
1,104,429
579,924